Sanchez Ramiro

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sanchez Ramiro's trades of Rapport Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-23 2026-10-23
B Purchase
43,075 -7.2%
202.41
US$3,913,468 		43,075 -7.2% 202.41 US$3,913,468
2023-12-28 2023-12-26
PlS Planned sale
78,831 +49.9%
473.17
US$2,875,476 		78,831 +49.9% 473.17 US$2,875,476
2023-12-26 2023-12-26
PrS Proposed sale
1,537
260.53
US$1,891,472 		1,537 260.53 US$1,891,472
2023-12-21 2023-12-20
S Sale
10,152 -40.9%
41.42
US$420,528 		10,152 -40.9% 41.42 US$420,528
2023-12-19 2023-12-15
S Sale
7,500 -100.0%
41.39
US$310,393 		7,500 -100.0% 41.39 US$310,393
2023-12-15 2023-12-15
PrS Proposed sale
7,500
41.39
US$310,392 		7,500 41.39 US$310,392
2023-12-11 2023-12-07
PlS Planned sale
10,000 -100.0%
41.37
US$413,700 		10,000 -100.0% 41.37 US$413,700
2023-12-07 2023-12-07
PrS Proposed sale
10,000
41.37
US$413,700 		10,000 41.37 US$413,700